质子泵抑制剂优化应用专家共识(2020版)

2020-05-02 中国药学会 中国医院药学杂志

质子泵抑制剂(Proton Pump Inhibitors,PPIs)作用于H+-K+-ATP 酶,能抑制基础的以及各种原因刺激导致的胃酸分泌。目

中文标题:

质子泵抑制剂优化应用专家共识(2020版)

发布机构:

中国药学会

发布日期:

2020-05-02

简要介绍:

质子泵抑制剂(Proton Pump Inhibitors,PPIs)作用于H+-K+-ATP 酶,能抑制基础的以及各种原因刺激导致的胃酸分泌。目前,国内外临床诊疗威廉亚洲博彩公司 、专家共识或指导原则多从疾病治疗角度阐述PPIs 的应用,涉及PPIs 合理使用、优化建议、药学规范的内容较为缺乏。为此,威廉亚洲博彩公司 制订工作组针对PPIs 临床使用中的适应证、用药方案、给药途径、给药方式、给药频率和时间、配制与保存、特殊人群用药、药物相互作用及安全性等药学监护点查阅大量权威文献,结合多专科医师、药师、护士和药物经济学家的经验,参考患者的意愿,为临床医师、药师和护士提供一个全面的PPIs 药学合理性应用规范,以期在临床工作中为促进临床合理用药,减轻患者经济负担,保障医疗质量和提高医疗安全发挥积极作用。

相关资料下载:
[AttachmentFileName(sort=1, fileName=【医脉通】质子泵抑制剂优化应用专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0efbd1c0026533c3, title=质子泵抑制剂优化应用专家共识(2020版), enTitle=, guiderFrom=中国医院药学杂志, authorId=0, author=, summary=质子泵抑制剂(Proton Pump Inhibitors,PPIs)作用于H+-K+-ATP 酶,能抑制基础的以及各种原因刺激导致的胃酸分泌。目, cover=https://img.medsci.cn/Random/pexels-photo-3873168.jpeg, journalId=0, articlesId=null, associationId=177, associationName=中国药学会, associationIntro=中国药学会成立于1907年,是中国最早成立的学术团体之一,是由全国药学科学技术工作者自愿组成依法登记成立的学术性、公益性、非盈利性的法人社会团体,是党和政府联系我国药学科学技术工作者的桥梁和纽带,是国家推动药学科学技术和民族医药事业健康发展,为公共健康服务的重要力量。中国药学会是国际药学联合会和亚洲药物化学联合会成员。现有注册会员8万多人,高级会员3000余人,团体会员53个。学会下设7个工作委员会,19个专业委员会,主办20种学术期刊。, copyright=0, guiderPublishedTime=Sat May 02 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">质子泵抑制剂(Proton Pump Inhibitors,PPIs)作用于H+-K+-ATP 酶,能抑制基础的以及各种原</span><span style="color: #333333;">因刺激导致的胃酸分泌。</span><span style="color: #333333;">目前,国内外临床诊疗威廉亚洲博彩公司 、专家共识或指导原则多从疾病治疗角度阐述PPIs 的应用,涉及</span><span style="color: #333333;">PPIs 合理使用、优化建议、药学规范的内容较为缺乏。为此,威廉亚洲博彩公司 制订工作组针对PPIs 临床使用中</span><span style="color: #333333;">的适应证、用药方案、给药途径、给药方式、给药频率和时间、配制与保存、特殊人群用药、药物相</span><span style="color: #333333;">互作用及安全性等药学监护点查阅大量权威文献,结合多专科医师、药师、护士和药物经济学家的经</span><span style="color: #333333;">验,参考患者的意愿,为临床医师、药师和护士提供一个全面的PPIs 药学合理性应用规范,以期在</span><span style="color: #333333;">临床工作中为促进临床合理用药,减轻患者经济负担,保障医疗质量和提高医疗安全发挥积极作用。</span></p>, tagList=[TagDto(tagId=1156, tagName=消化科), TagDto(tagId=1835, tagName=质子泵抑制剂), TagDto(tagId=7758, tagName=药械)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4438, appHits=123, showAppHits=0, pcHits=461, showPcHits=4315, likes=1, shares=22, comments=5, approvalStatus=1, publishedTime=Wed Sep 07 15:09:22 CST 2022, publishedTimeString=2020-05-02, pcVisible=1, appVisible=1, editorId=0, editor=艺玮, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=艺玮, createdTime=Wed Sep 07 15:11:04 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 05:29:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=【医脉通】质子泵抑制剂优化应用专家共识.pdf)])
【医脉通】质子泵抑制剂优化应用专家共识.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2089945, encodeId=4692208994535, content=好想下载呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=669b6497253, createdName=ms3000001890047386, createdTime=Fri Sep 23 14:08:30 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249510, encodeId=202e12495102a, content=<a href='/topic/show?id=02f99235e23' target=_blank style='color:#2F92EE;'>#质子泵抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92357, encryptionId=02f99235e23, topicName=质子泵抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:29:18 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247859, encodeId=4625124e85909, content=好想下载啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f888315129, createdName=ms2000001090218216, createdTime=Thu Sep 08 11:05:11 CST 2022, time=2022-09-08, status=1, ipAttribution=)]
    2022-09-23 ms3000001890047386

    好想下载呀

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2089945, encodeId=4692208994535, content=好想下载呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=669b6497253, createdName=ms3000001890047386, createdTime=Fri Sep 23 14:08:30 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249510, encodeId=202e12495102a, content=<a href='/topic/show?id=02f99235e23' target=_blank style='color:#2F92EE;'>#质子泵抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92357, encryptionId=02f99235e23, topicName=质子泵抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:29:18 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247859, encodeId=4625124e85909, content=好想下载啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f888315129, createdName=ms2000001090218216, createdTime=Thu Sep 08 11:05:11 CST 2022, time=2022-09-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2089945, encodeId=4692208994535, content=好想下载呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=669b6497253, createdName=ms3000001890047386, createdTime=Fri Sep 23 14:08:30 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249510, encodeId=202e12495102a, content=<a href='/topic/show?id=02f99235e23' target=_blank style='color:#2F92EE;'>#质子泵抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92357, encryptionId=02f99235e23, topicName=质子泵抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:29:18 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247859, encodeId=4625124e85909, content=好想下载啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f888315129, createdName=ms2000001090218216, createdTime=Thu Sep 08 11:05:11 CST 2022, time=2022-09-08, status=1, ipAttribution=)]
    2022-09-08 ms2000001090218216

    好想下载啊

    0